Wearable sensor

- Biolinq Incorporated
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front perspective view of a wearable sensor showing the new design;

FIG. 2 is a top plan view thereof;

FIG. 3 is a bottom plan view thereof;

FIG. 4 is a right side view thereof;

FIG. 5 is a left side view thereof;

FIG. 6 is a rear view thereof;

FIG. 7 is a front view thereof;

FIG. 8 is a front perspective view of another wearable sensor showing the new design;

FIG. 9 is a top plan view thereof;

FIG. 10 is a bottom plan view thereof;

FIG. 11 is a right side view thereof;

FIG. 12 is a left side view thereof;

FIG. 13 is a rear view thereof; and,

FIG. 14 is a front view thereof.

The broken lines are for the purpose of illustrating portions of the article and form no part of the claimed design.

Claims

The ornamental design for a wearable sensor, as shown and described.

Referenced Cited
U.S. Patent Documents
4305401 December 15, 1981 Reissmueller et al.
4323996 April 6, 1982 Ganter
4407295 October 4, 1983 Steuer et al.
5131390 July 21, 1992 Sakaguchi et al.
5279543 January 18, 1994 Glikfeld et al.
5286364 February 15, 1994 Yacynych et al.
5540828 July 30, 1996 Yacynych
5730714 March 24, 1998 Guy et al.
5766132 June 16, 1998 Yasukawa et al.
6036055 March 14, 2000 Mogadam et al.
6139718 October 31, 2000 Kurnik et al.
6269053 July 31, 2001 Kawata et al.
6284126 September 4, 2001 Kurnik et al.
6413396 July 2, 2002 Yang et al.
6471903 October 29, 2002 Sherman et al.
6603987 August 5, 2003 Whitson
6814845 November 9, 2004 Wilson et al.
6862466 March 1, 2005 Ackerman
6908453 June 21, 2005 Fleming et al.
7097776 August 29, 2006 Govinda Raju
7132054 November 7, 2006 Kravitz et al.
7262068 August 28, 2007 Roy et al.
7343188 March 11, 2008 Sohrab
7344499 March 18, 2008 Prausnitz et al.
7429333 September 30, 2008 Chiou et al.
7456112 November 25, 2008 Lee
7493232 February 17, 2009 Surina
8022292 September 20, 2011 Arianpour et al.
8060318 November 15, 2011 Vering et al.
8088321 January 3, 2012 Ferguson et al.
8094009 January 10, 2012 Allen et al.
8125331 February 28, 2012 Allen et al.
8130095 March 6, 2012 Allen et al.
8280475 October 2, 2012 Brister et al.
8284046 October 9, 2012 Allen et al.
8574165 November 5, 2013 Marsh
8750955 June 10, 2014 Brister et al.
8798799 August 5, 2014 Deo et al.
8909543 December 9, 2014 Tropper et al.
D722697 February 17, 2015 Moon et al.
9041730 May 26, 2015 Johnson et al.
9055901 June 16, 2015 Brister et al.
9107623 August 18, 2015 Brauker et al.
D750786 March 1, 2016 Davies et al.
D757000 May 24, 2016 Lagomarsino et al.
D771824 November 15, 2016 Minoli
D776285 January 10, 2017 Dinger
9551698 January 24, 2017 Huys et al.
D794801 August 15, 2017 Newhouse
9717843 August 1, 2017 Grucela et al.
9737247 August 22, 2017 Wang et al.
9743870 August 29, 2017 Wang et al.
D815289 April 10, 2018 Evers et al.
D816229 April 24, 2018 Frick et al.
9933387 April 3, 2018 McCanna et al.
D820988 June 19, 2018 Pushpala et al.
D821571 June 26, 2018 Stonecipher
10004435 June 26, 2018 Larvenz et al.
10029043 July 24, 2018 Grucela et al.
10092207 October 9, 2018 Windmiller
10136846 November 27, 2018 Wang et al.
D842996 March 12, 2019 Frick et al.
D845289 April 9, 2019 Chuang et al.
10251565 April 9, 2019 Chan et al.
10321859 June 18, 2019 Wynbrandt et al.
D853382 July 9, 2019 Haigh
10362973 July 30, 2019 Hernandez-Rosas et al.
D867911 November 26, 2019 Alabdin
D870291 December 17, 2019 Barry
10492708 December 3, 2019 Windmiller
D875254 February 11, 2020 Cooke et al.
D882432 April 28, 2020 Yee et al.
10765369 September 8, 2020 Antonio et al.
D903877 December 1, 2020 Pace
11039767 June 22, 2021 Hayter
11045142 June 29, 2021 Windmiller et al.
11087868 August 10, 2021 Budiman
11102306 August 24, 2021 Mensinger et al.
11141116 October 12, 2021 Cabrera, Jr. et al.
11150145 October 19, 2021 Nekoomaram et al.
11154253 October 26, 2021 Cabrera, Jr. et al.
11182332 November 23, 2021 Anderson et al.
11197626 December 14, 2021 Koehler et al.
11205511 December 21, 2021 Hayter et al.
11207025 December 28, 2021 Trapero et al.
11272890 March 15, 2022 McGarraugh
11305906 April 19, 2022 Grucela et al.
11357430 June 14, 2022 Pushpala et al.
11373347 June 28, 2022 Kamath et al.
D957438 July 12, 2022 Hayter et al.
D958817 July 26, 2022 Mensinger et al.
11389088 July 19, 2022 Desborough et al.
D960895 August 16, 2022 Mensinger
D962446 August 30, 2022 Bernstein
11406331 August 9, 2022 Budiman
11406818 August 9, 2022 Windmiller
11437141 September 6, 2022 Mensinger et al.
11446108 September 20, 2022 Larson et al.
D967128 October 18, 2022 Kumar et al.
D967136 October 18, 2022 Kumar et al.
11464459 October 11, 2022 Sjolund et al.
11475988 October 18, 2022 Burkart et al.
11478194 October 25, 2022 Windmiller
11497422 November 15, 2022 Koehler et al.
11507530 November 22, 2022 Anderson et al.
11517222 December 6, 2022 Pushpala et al.
11534089 December 27, 2022 Taub et al.
11547799 January 10, 2023 Zhong et al.
11576600 February 14, 2023 Lee et al.
11654270 May 23, 2023 Mansfield, III et al.
11660392 May 30, 2023 Kamen et al.
D988160 June 6, 2023 Morelock
11672965 June 13, 2023 Mansfield et al.
D996999 August 29, 2023 Morelock
D1012744 January 30, 2024 Morelock
11857344 January 2, 2024 Windmiller et al.
11872055 January 16, 2024 Tangney et al.
20030225360 December 4, 2003 Eppstein et al.
20060015061 January 19, 2006 Kuo et al.
20070170054 July 26, 2007 Wilsey
20070213044 September 13, 2007 Steingart et al.
20090088652 April 2, 2009 Tremblay
20090143761 June 4, 2009 Cantor et al.
20090259118 October 15, 2009 Feldman et al.
20100056873 March 4, 2010 Allen et al.
20100286803 November 11, 2010 Tillotson et al.
20120323097 December 20, 2012 Chowdhury
20130065257 March 14, 2013 Wang et al.
20130144131 June 6, 2013 Wang et al.
20140259652 September 18, 2014 Pushpala et al.
20140275897 September 18, 2014 Pushpala et al.
20140336487 November 13, 2014 Wang et al.
20150335272 November 26, 2015 Natale et al.
20170003766 January 5, 2017 Budiman
20170055851 March 2, 2017 Al-Ali
20170215774 August 3, 2017 Koehler et al.
20170290532 October 12, 2017 Antonio
20180116572 May 3, 2018 Simpson
20180249937 September 6, 2018 Wiese et al.
20190095602 March 28, 2019 Setlak et al.
20190125223 May 2, 2019 Wang et al.
20190133638 May 9, 2019 Ii
20190167167 June 6, 2019 Mitchell et al.
20190246914 August 15, 2019 Constantin et al.
20190246973 August 15, 2019 Constantin et al.
20190274603 September 12, 2019 Ringemann
20190307376 October 10, 2019 Hernandez-Rosas et al.
20190309433 October 10, 2019 Sattayasamitsathit et al.
20200085341 March 19, 2020 Windmiller
20200101286 April 2, 2020 Windmiller et al.
20200146598 May 14, 2020 Mayou et al.
20200214566 July 9, 2020 Allen et al.
20200245914 August 6, 2020 Bhavaraju et al.
20200254240 August 13, 2020 Windmiller et al.
20200275870 September 3, 2020 Bhavaraju et al.
20200297997 September 24, 2020 Windmiller et al.
20200337615 October 29, 2020 Larvenz et al.
20210161436 June 3, 2021 Troncelliti et al.
20210169384 June 10, 2021 Taub et al.
20210187286 June 24, 2021 Windmiller et al.
20210196162 July 1, 2021 Halac et al.
20210236057 August 5, 2021 Pushpala et al.
20210282672 September 16, 2021 Kumar et al.
20210321914 October 21, 2021 Brister et al.
20210335499 October 28, 2021 Simpson et al.
20210361199 November 25, 2021 Kumar
20210378601 December 9, 2021 Kumar et al.
20210393201 December 23, 2021 Morelock et al.
20220000399 January 6, 2022 Hayter et al.
20220000432 January 6, 2022 Cabrera, Jr. et al.
20220031209 February 3, 2022 Windmiller et al.
20220031244 February 3, 2022 Windmiller et al.
20220057868 February 24, 2022 Budiman
20220080678 March 17, 2022 Cole et al.
20220087610 March 24, 2022 Pushpala et al.
20220101995 March 31, 2022 Johnson et al.
20220142524 May 12, 2022 Harper et al.
20220142589 May 12, 2022 Lee
20220175278 June 9, 2022 Campbell et al.
20220194644 June 23, 2022 Grucela et al.
20220202319 June 30, 2022 Crawford et al.
20220202320 June 30, 2022 Diener et al.
20220216735 July 7, 2022 Yan et al.
20220265224 August 25, 2022 Hauptman et al.
20220283042 September 8, 2022 Nekoomaram et al.
20220292746 September 15, 2022 Kamath et al.
20220336100 October 20, 2022 Chiu et al.
20220361825 November 17, 2022 Kang
20220370011 November 24, 2022 Windmiller et al.
20220392643 December 8, 2022 Mensinger et al.
20230005588 January 5, 2023 Sokolovskyy et al.
20230074798 March 9, 2023 Tangney et al.
20230094419 March 30, 2023 Mansfield, III et al.
20230099617 March 30, 2023 Mansfield, III et al.
20230137258 May 4, 2023 Windmiller
20230190147 June 22, 2023 Campbell et al.
20230256220 August 17, 2023 Mansfield, III et al.
20230301552 September 28, 2023 Mallires et al.
20230310823 October 5, 2023 Mansfield et al.
20230414102 December 28, 2023 Allen et al.
20240008777 January 11, 2024 Fuchs et al.
Foreign Patent Documents
717520 December 2021 CH
306169676 November 2020 CN
001371280-0001 June 2013 EM
3871602 September 2021 EP
3042872 December 2020 FR
6192168 February 2022 GB
1721016 July 2022 JP
WO-2009034313 March 2009 WO
WO-2009034313 March 2009 WO
WO-2009064164 May 2009 WO
WO-2009064164 May 2009 WO
WO-2010120364 October 2010 WO
WO-2010120364 October 2010 WO
WO-2012020332 February 2012 WO
WO-2012020332 February 2012 WO
WO-2013058879 April 2013 WO
WO-2013058879 April 2013 WO
WO-2020073060 April 2020 WO
WOD214300-002 May 2021 WO
WO-2021148596 July 2021 WO
WO-2022044017 March 2022 WO
WO-2022031792 April 2022 WO
WO-2022044018 April 2022 WO
WO-2022266443 December 2022 WO
WO-2023055755 April 2023 WO
WO-2023064877 April 2023 WO
WO-2023133468 July 2023 WO
WO-2023229662 November 2023 WO
WO-2024010827 January 2024 WO
Other references
  • Abbott, Abbott's FreeStyle® Libre 3 System Receives CE Mark, Published on: Sep. 28, 2020, PRNewswire.com, Retrieved from Internet: (Year: 2020).
  • https://www.prnewswire.com/news-releases/abbotts-freestyle-libre-3-system-receives-ce-mark--features-worlds-smallest-thinnest-sensor-with-best-in-class-performance-at-the-same-low-cost-for-people-with-diabetes-301138719.html (Year: 2020).
  • Garg et al., Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes, Published on: May 31, 2022, Diabetes Technology & Therapeutics, Retrieved from Internet: https://www.liebertpub.com/doi/10.1089/dia.2022.0011 (Year: 2022).
  • Biolinq, Biolinq Announces Results from First-in-Man Clinical Studies Showing Feasibility of a Novel, Minimally Invasive Approach to Continuous Glucose Monitoring in the Dermis, Published on: Jun. 15, 2020, PRNewswire.com, Retrieved from Internet: https://www.prnewswire.com/news-releases/biolinq-announces-results-from-first-in-man-clinical-studies-showing-feasibility-of-a-novel-minimally-invasive-approach-to-continuous-glucose-monitoring-in-the-dermis-301076992.html (Year: 2020).
  • Delve, Dexcom G6, Published in: 2019, Designdirectory.com, Retrieved from Internet: https://www.designdirectory.com/delve/Dexcom-G6?AspxAutoDetectCookieSupport=1 (Year: 2019).
  • Diabetes.co.uk, FDA approves new CGM the Abbott FreeStyle Libre Pro System, Published on: Sep. 29, 2016, diabetes.co.uk, Retrieved from Internet: https://www.diabetes.co.uk/news/2016/sep/fda-approves-new-cgm-the-abbott-freestyle-libre-pro-system-90611033.html (Year: 2016).
  • Idrus, Medtronic integrates CGM, Fitbit data into mobile app, Published on: Dec. 19, 2016, Fierce Biotech.com, Retrieved from Internet: https://www.fiercebiotech.com/medical-devices/medtronic-integrates-cgm-fitbit-data-into-mobile-app (Year: 2016).
  • Roche Diabetes Care, Roche Diabetes Care y Senseonics anuncian un acuerdo de distribución para el sistema Eversense® CGM, Published on: May 26, 2016, PRNewswire.com, Retrieved from Internet: https://www.prnewswire.com/news-releases/roche-diabetes-care-y-senseonics-anuncian-un-acuerdo-de-distribucion-para-el-sistema-eversense-cgm-580978821.html (Year: 2016).
  • WaveForm Technologies Inc., WaveForm Technologies Inc. Awarded CE Mark Approval for Their Continuous Glucose Monitoring System, Published on: Nov. 5, 2019, PRNewswire.com, Retrieved from Internet: https://www.prnewswire.com/news-releases/waveform-technologies-inc-awarded-ce-mark-approval-for-their-continuous-glucose-monitoring-system-300952002.html (Year: 2019).
  • Abbot press release (2020). “New late-breaking data show use of Abbott's Freestyle® Libre System significantly reduces HBA1C levels in people with type 2 diabetes using insulin or not,” 3 pages.
  • Al Hayek et al., “Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study” Cureus Oct. 27, 2020; 12(10):e11195. 8 pages. doi: 10.7759/cureus.11195.
  • Allen et al., “Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial” Diabetes Res Clin Pract. Jun. 2008; 80(3):371-379. doi:10.1016/j.diabres.2008.01.006.
  • American Diabetes Association® Press Release (2020). “American Diabetes Association® Applauds policymakers' Focus on Addressing High Costs of Insulin for Seven Million Americans,” 4 pages.
  • Bantle, J.P. et al. (1997). “Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid,” J. Lab. Clin. Med. 130:436-441.
  • Barrett et al., “Risk for Newly Diagnosed Diabetes 30 Days After SARS-CoV-2 Infection Among Persons Aged 18 Years—United States, Mar. 1, 2020-Jun. 28, 2021” MMWR Morb Mortal Wkly Rep. Jan. 14, 2022; 71(2):59-65. doi: 10.15585/mmwr.mm7102e2.
  • Beckles, G.L. et al. (2016). “Disparities in the prevalence of diagnosed diabetes—United States, 1999-2002 and 2011-2014,” MMWR 65:1265-1269.
  • Biolinq, Inc. (2019). The Intelligent Continuous Glucose Monitoring System, 5 total pages.
  • Cao, J. et al. (2017). “Validation of capillary blood analysis and capillary testing mode on the epoc Point of Care system,” Pract. Lab. Med. 9:24-27.
  • Castle, J.R. et al. (2012). “The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes,” Diabetes Care 35:706-710.
  • Centers for Disease Control, “National Diabetes Statistics Report 2020 Estimates of Diabetes and Its Burden in the United States” (2020) 32 pages.
  • Dexcom (2020). Analyst Day Presentation, 19 total pages.
  • Dexcom (2020). Analyst Day Presentation, 27 total pages.
  • Diabetes Care (2021). “7. Diabetes Technology: Standards of Medical Care in Diabetes—2021,” Diabetes Care 44(Supplement 1):S85-S99.
  • Dunkin et al., “Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers” Plast Reconstr Surg. May 2007; 119(6):1722-1732. doi: 10.1097/01.prs.0000258829.07399.f0.
  • Ehrhardt et al., “Behavior Modification in Prediabetes and Diabetes: Potential Use of Real-Time Continuous Glucose Monitoring” Journal of Diabetes Science and Technology Mar. 2019; 13(2):271-275.
  • Ehrhardt et al., “Continuous Glucose Monitoring As a Behavior Modification Tool” Clin Diabetes. Apr. 2020; 38(2):126-131. doi: 10.2337/cd19-0037.
  • Ehrhardt et al, “The Effect of Real-Time Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Mellitus” Journal of Diabetes Science and Technology May 2011; 5(3):668-675.
  • Fang, M. et al. (2021). “Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018,” N. Engl. Med. 384:2219-2228.
  • Fonda et al., “The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes” Journal of Diabetes Science and Technology (2016) 10(4):898-904.
  • French, D.P. et al. (2008). “Original Article: Psychological Care Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial,” Diav. Med. 25:1218-1228.
  • Grady, M. et al. (2017). “Examining the Impact of a Novel Blood Glucose Monitor with Color Range Indicator on Decision-Making in Patients With Type 1 and Type 2 Diabetes and its Association With Patient Numeracy Level,” JMIR Diabetes 2:e24. 11 pages.
  • Grady, M. et al. (2018). “Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients with Diabetes in Comparison to Blood Glucose Meters Without Color (Accents Study),” J. Diab. Sci. Tech. 12:1211-1219.
  • Groenendaal, W. et al. (2008). “Modeling Glucose and Water Dynamics in Human Skin,” Diab. Tech. Therap. 10:283-293.
  • Han et al., “The End of the Road for the YSI 2300 Analyzer: Where Do We Go Now?” Journal of Diabetes Science and Technology (2020) 14(3):595-600.
  • Han et al., “The YSI 2300 Analyzer Replacement Meeting Report” Journal of Diabetes Science and Technology (2020) 14(3):679-686.
  • Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008). “Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes,” N. Engl. Med. 359:1464-1476.
  • Karter, A.J. et al. (2021). “Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes,” JAMA 325:2273-2284.
  • Martens, T. et al. (2021). “Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin A Randomized Clinical Trial,” JAMA 325:2262-2272.
  • McClatchey, P.M. et al. (2019). “Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays,” Diabetes 68:1892-1901.
  • Neerken, S. et al. (2004). “Characterization of age-related effects in human skin: A comparative study that applies confocal laser scanning microscopy and optical coherence tomography,” J. Biomed. Optics 9:274-281.
  • Non-Final Office Action mailed on Nov. 14, 2019, for U.S. Appl. No. 29/650,794, filed Jun. 8, 2018, 10 pages.
  • Notice of Allowance mailed on Dec. 18, 2019, for U.S. Appl. No. 29/650,794, filed Jun. 8, 2018, 7 pages.
  • Notice of Allowance mailed on Sep. 29, 2022, for U.S. Appl. No. 29/774,399, filed Mar. 16, 2021, 7 pages.
  • Notice of Allowance mailed on Jan. 25, 2023, for U.S. Appl. No. 29/774,399, filed Mar. 16, 2021, 11 pages.
  • Notice of Allowance mailed on Mar. 1, 2023, for U.S. Appl. No. 29/815,797, filed Nov. 16, 2021, 10 pages.
  • Notice of Allowance mailed on May 17, 2023, for U.S. Appl. No. 29/836,984, filed Apr. 29, 2022, 7 pages.
  • Notice of Allowance mailed on May 31, 2023, for U.S. Appl. No. 29/838,870, filed May 16, 2022, 7 pages.
  • Notice of Allowance mailed on Jun. 14, 2023, for U.S. Appl. No. 29/815,797, filed Nov. 16, 2021, 9 pages.
  • Polonsky, W.H. et al. (2011). “A survey of blood glucose monitoring in patients with type 2 diabetes: Are recommendations from health care professionals being followed?” Curr. Med. Res. & Opinion 27:31-37.
  • Rigla, M. et al. (2018). “Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy,” Diabetes Technology & Therapeutics 20:296-302.
  • Sharifi et al., “Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring” Journal of Diabetes Science and Technology (2016) 10(3):669-678.
  • Sheikh, Z. et al. (2015). “Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials,” Materials 8:5671-5701.
  • Shi, T. et al. (2016). “Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes,” J. Diab. Res. vol. 2016, 9 pages.
  • Turner et al., “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)” The Lancet Sep. 1998; 352(9131):837-853.
  • Vigersky et al., “Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients with Type 2 Diabetes” Diabetes Care Jan. 2012; 35:32-38.
  • Wolicki et al., “Epidemiology and Prevention of Vaccine-Preventable Diseases: Chapter 6: Vaccine Administration” Centers for Disease Control and Prevention (2021) 17 pages.
  • World Health Organization, “Diabetes”, Sep. 16, 2022, 5 pages.
  • Young et al., “Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial” JAMA Intern Med. Jul. 2017; 177(7):920-929.
  • Notice of Allowance mailed on Nov. 22, 2023, for U.S. Appl. No. 29/838,870, filed May 16, 2022, 7 pages.
  • Notice of Allowance mailed on Nov. 29, 2023, for U.S. Appl. No. 29/836,984, filed Apr. 29, 2022, 7 pages.
Patent History
Patent number: D1035004
Type: Grant
Filed: Feb 28, 2023
Date of Patent: Jul 9, 2024
Assignee: Biolinq Incorporated (San Diego, CA)
Inventor: David Michael Morelock (Escondido, CA)
Primary Examiner: Jennifer L Rempfer
Assistant Examiner: Edward P Jones
Application Number: 29/871,863
Classifications
Current U.S. Class: Hematological Or Intravenous Treatment (41) (D24/169)